Ardena has extensive experience formulating drug products for early development. The breadth of our technologies enables us to provide a drug product that can be consistently prepared and accurately dosed, and that allows for mastering of potential solubility and bioavailability challenges.
A highly skilled team, actively supported by CMC experts, approaches formulation options in function of risk assessment frameworks. By navigating through a complex regulatory environment, a complete IMPD dossier is delivered on time.
Access the full info sheet here.
